Global Guaifenesin (API) Market Research Report 2020

Publisher Name :
Date: 01-Jan-2020
No. of pages: 117
Inquire Before Buying

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.

The global average price of Guaifenesin (API) is in the decreasing trend, from 8.62 USD/Kg in 2012 to 7.61 USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.

The global Guaifenesin (API) market is valued at 56 million US$ in 2020 is expected to reach 58 million US$ by the end of 2026, growing at a CAGR of 0.5% during 2021-2026.

This report focuses on Guaifenesin (API) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Guaifenesin (API) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Guaifenesin (API) market is segmented into

- 98%-99%

- >99%

Segment by Application

- Pharmaceuticals

- Others

Global Guaifenesin (API) Market: Regional Analysis

The Guaifenesin (API) market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Guaifenesin (API) market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Guaifenesin (API) Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Guaifenesin (API) market include:

- Granules

- Synthokem Labs

- Haizhou Pharma

- Yuan Cheng Group

- Stellar Chemical

- Biesterfeld

- Seven Star Pharma

- Camlin Fine Science

- Gennex Lab

- Iwaki Seiyaku

- Pan Drugs

- Delta Synthetic

- Smart Pharm

Global Guaifenesin (API) Market Research Report 2020

Table of Contents
1 Guaifenesin (API) Market Overview
1.1 Product Overview and Scope of Guaifenesin (API)
1.2 Guaifenesin (API) Segment by Type
1.2.1 Global Guaifenesin (API) Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 98%-99%
1.2.3 >99%
1.3 Guaifenesin (API) Segment by Application
1.3.1 Guaifenesin (API) Sales Comparison by Application: 2020 VS 2026
1.3.2 Pharmaceuticals
1.3.3 Others
1.4 Global Guaifenesin (API) Market Size Estimates and Forecasts
1.4.1 Global Guaifenesin (API) Revenue 2015-2026
1.4.2 Global Guaifenesin (API) Sales 2015-2026
1.4.3 Guaifenesin (API) Market Size by Region: 2020 Versus 2026
2 Global Guaifenesin (API) Market Competition by Manufacturers
2.1 Global Guaifenesin (API) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Guaifenesin (API) Revenue Share by Manufacturers (2015-2020)
2.3 Global Guaifenesin (API) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Guaifenesin (API) Manufacturing Sites, Area Served, Product Type
2.5 Guaifenesin (API) Market Competitive Situation and Trends
2.5.1 Guaifenesin (API) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Guaifenesin (API) Players (Opinion Leaders)
3 Guaifenesin (API) Retrospective Market Scenario by Region
3.1 Global Guaifenesin (API) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Guaifenesin (API) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Guaifenesin (API) Market Facts & Figures by Country
3.3.1 North America Guaifenesin (API) Sales by Country
3.3.2 North America Guaifenesin (API) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Guaifenesin (API) Market Facts & Figures by Country
3.4.1 Europe Guaifenesin (API) Sales by Country
3.4.2 Europe Guaifenesin (API) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Guaifenesin (API) Market Facts & Figures by Region
3.5.1 Asia Pacific Guaifenesin (API) Sales by Region
3.5.2 Asia Pacific Guaifenesin (API) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Guaifenesin (API) Market Facts & Figures by Country
3.6.1 Latin America Guaifenesin (API) Sales by Country
3.6.2 Latin America Guaifenesin (API) Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Guaifenesin (API) Market Facts & Figures by Country
3.7.1 Middle East and Africa Guaifenesin (API) Sales by Country
3.7.2 Middle East and Africa Guaifenesin (API) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Guaifenesin (API) Historic Market Analysis by Type
4.1 Global Guaifenesin (API) Sales Market Share by Type (2015-2020)
4.2 Global Guaifenesin (API) Revenue Market Share by Type (2015-2020)
4.3 Global Guaifenesin (API) Price Market Share by Type (2015-2020)
4.4 Global Guaifenesin (API) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Guaifenesin (API) Historic Market Analysis by Application
5.1 Global Guaifenesin (API) Sales Market Share by Application (2015-2020)
5.2 Global Guaifenesin (API) Revenue Market Share by Application (2015-2020)
5.3 Global Guaifenesin (API) Price by Application (2015-2020)
6 Company Profiles and Key Figures in Guaifenesin (API) Business
6.1 Granules
6.1.1 Corporation Information
6.1.2 Granules Description, Business Overview and Total Revenue
6.1.3 Granules Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Granules Products Offered
6.1.5 Granules Recent Development
6.2 Synthokem Labs
6.2.1 Synthokem Labs Guaifenesin (API) Production Sites and Area Served
6.2.2 Synthokem Labs Description, Business Overview and Total Revenue
6.2.3 Synthokem Labs Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Synthokem Labs Products Offered
6.2.5 Synthokem Labs Recent Development
6.3 Haizhou Pharma
6.3.1 Haizhou Pharma Guaifenesin (API) Production Sites and Area Served
6.3.2 Haizhou Pharma Description, Business Overview and Total Revenue
6.3.3 Haizhou Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Haizhou Pharma Products Offered
6.3.5 Haizhou Pharma Recent Development
6.4 Yuan Cheng Group
6.4.1 Yuan Cheng Group Guaifenesin (API) Production Sites and Area Served
6.4.2 Yuan Cheng Group Description, Business Overview and Total Revenue
6.4.3 Yuan Cheng Group Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Yuan Cheng Group Products Offered
6.4.5 Yuan Cheng Group Recent Development
6.5 Stellar Chemical
6.5.1 Stellar Chemical Guaifenesin (API) Production Sites and Area Served
6.5.2 Stellar Chemical Description, Business Overview and Total Revenue
6.5.3 Stellar Chemical Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Stellar Chemical Products Offered
6.5.5 Stellar Chemical Recent Development
6.6 Biesterfeld
6.6.1 Biesterfeld Guaifenesin (API) Production Sites and Area Served
6.6.2 Biesterfeld Description, Business Overview and Total Revenue
6.6.3 Biesterfeld Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Biesterfeld Products Offered
6.6.5 Biesterfeld Recent Development
6.7 Seven Star Pharma
6.6.1 Seven Star Pharma Guaifenesin (API) Production Sites and Area Served
6.6.2 Seven Star Pharma Description, Business Overview and Total Revenue
6.6.3 Seven Star Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Seven Star Pharma Products Offered
6.7.5 Seven Star Pharma Recent Development
6.8 Camlin Fine Science
6.8.1 Camlin Fine Science Guaifenesin (API) Production Sites and Area Served
6.8.2 Camlin Fine Science Description, Business Overview and Total Revenue
6.8.3 Camlin Fine Science Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Camlin Fine Science Products Offered
6.8.5 Camlin Fine Science Recent Development
6.9 Gennex Lab
6.9.1 Gennex Lab Guaifenesin (API) Production Sites and Area Served
6.9.2 Gennex Lab Description, Business Overview and Total Revenue
6.9.3 Gennex Lab Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Gennex Lab Products Offered
6.9.5 Gennex Lab Recent Development
6.10 Iwaki Seiyaku
6.10.1 Iwaki Seiyaku Guaifenesin (API) Production Sites and Area Served
6.10.2 Iwaki Seiyaku Description, Business Overview and Total Revenue
6.10.3 Iwaki Seiyaku Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Iwaki Seiyaku Products Offered
6.10.5 Iwaki Seiyaku Recent Development
6.11 Pan Drugs
6.11.1 Pan Drugs Guaifenesin (API) Production Sites and Area Served
6.11.2 Pan Drugs Guaifenesin (API) Description, Business Overview and Total Revenue
6.11.3 Pan Drugs Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Pan Drugs Products Offered
6.11.5 Pan Drugs Recent Development
6.12 Delta Synthetic
6.12.1 Delta Synthetic Guaifenesin (API) Production Sites and Area Served
6.12.2 Delta Synthetic Guaifenesin (API) Description, Business Overview and Total Revenue
6.12.3 Delta Synthetic Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Delta Synthetic Products Offered
6.12.5 Delta Synthetic Recent Development
6.13 Smart Pharm
6.13.1 Smart Pharm Guaifenesin (API) Production Sites and Area Served
6.13.2 Smart Pharm Guaifenesin (API) Description, Business Overview and Total Revenue
6.13.3 Smart Pharm Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Smart Pharm Products Offered
6.13.5 Smart Pharm Recent Development
7 Guaifenesin (API) Manufacturing Cost Analysis
7.1 Guaifenesin (API) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Guaifenesin (API)
7.4 Guaifenesin (API) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Guaifenesin (API) Distributors List
8.3 Guaifenesin (API) Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Guaifenesin (API) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Guaifenesin (API) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Guaifenesin (API) by Type (2021-2026)
10.2 Guaifenesin (API) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Guaifenesin (API) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Guaifenesin (API) by Application (2021-2026)
10.3 Guaifenesin (API) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Guaifenesin (API) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Guaifenesin (API) by Region (2021-2026)
10.4 North America Guaifenesin (API) Estimates and Projections (2021-2026)
10.5 Europe Guaifenesin (API) Estimates and Projections (2021-2026)
10.6 Asia Pacific Guaifenesin (API) Estimates and Projections (2021-2026)
10.7 Latin America Guaifenesin (API) Estimates and Projections (2021-2026)
10.8 Middle East and Africa Guaifenesin (API) Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Guaifenesin (API) Sales (MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Guaifenesin (API) Sales (MT) Comparison by Application: 2020 VS 2026
Table 3. Global Guaifenesin (API) Market Size by Type (MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Guaifenesin (API) Manufacturers Covered in This Study
Table 5. Global Guaifenesin (API) Sales (MT) by Manufacturers (2015-2020)
Table 6. Global Guaifenesin (API) Sales Share by Manufacturers (2015-2020)
Table 7. Global Guaifenesin (API) Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Guaifenesin (API) Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Guaifenesin (API) Average Price (USD/Kg) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Guaifenesin (API) Sales Sites and Area Served
Table 11. Manufacturers Guaifenesin (API) Product Types
Table 12. Global Guaifenesin (API) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Guaifenesin (API) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Guaifenesin (API) as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Guaifenesin (API) Players
Table 16. Global Guaifenesin (API) Sales (MT) by Region (2015-2020)
Table 17. Global Guaifenesin (API) Sales Market Share by Region (2015-2020)
Table 18. Global Guaifenesin (API) Revenue (Million US$) by Region (2015-2020)
Table 19. Global Guaifenesin (API) Revenue Market Share by Region (2015-2020)
Table 20. North America Guaifenesin (API) Sales by Country (2015-2020) (MT)
Table 21. North America Guaifenesin (API) Sales Market Share by Country (2015-2020)
Table 22. North America Guaifenesin (API) Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Guaifenesin (API) Revenue Market Share by Country (2015-2020)
Table 24. Europe Guaifenesin (API) Sales by Country (2015-2020) (MT)
Table 25. Europe Guaifenesin (API) Sales Market Share by Country (2015-2020)
Table 26. Europe Guaifenesin (API) Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Guaifenesin (API) Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Guaifenesin (API) Sales by Region (2015-2020) (MT)
Table 29. Asia Pacific Guaifenesin (API) Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Guaifenesin (API) Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Guaifenesin (API) Revenue Market Share by Region (2015-2020)
Table 32. Latin America Guaifenesin (API) Sales by Country (2015-2020) (MT)
Table 33. Latin America Guaifenesin (API) Sales Market Share by Country (2015-2020)
Table 34. Latin America Guaifenesin (API) Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Guaifenesin (API) Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Guaifenesin (API) Sales by Country (2015-2020) (MT)
Table 37. Middle East and Africa Guaifenesin (API) Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Guaifenesin (API) Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Guaifenesin (API) Revenue Market Share by Country (2015-2020)
Table 40. Global Guaifenesin (API) Sales (MT) by Type (2015-2020)
Table 41. Global Guaifenesin (API) Sales Share by Type (2015-2020)
Table 42. Global Guaifenesin (API) Revenue (Million US$) by Type (2015-2020)
Table 43. Global Guaifenesin (API) Revenue Share by Type (2015-2020)
Table 44. Global Guaifenesin (API) Price (USD/Kg) by Type (2015-2020)
Table 45. Global Guaifenesin (API) Sales (MT) by Application (2015-2020)
Table 46. Global Guaifenesin (API) Sales Market Share by Application (2015-2020)
Table 47. Global Guaifenesin (API) Sales Growth Rate by Application (2015-2020)
Table 48. Granules Guaifenesin (API) Corporation Information
Table 49. Granules Description and Business Overview
Table 50. Granules Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 51. Granules Main Product
Table 52. Granules Recent Development
Table 53. Synthokem Labs Guaifenesin (API) Corporation Information
Table 54. Synthokem Labs Corporation Information
Table 55. Synthokem Labs Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 56. Synthokem Labs Main Product
Table 57. Synthokem Labs Recent Development
Table 58. Haizhou Pharma Guaifenesin (API) Corporation Information
Table 59. Haizhou Pharma Corporation Information
Table 60. Haizhou Pharma Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 61. Haizhou Pharma Main Product
Table 62. Haizhou Pharma Recent Development
Table 63. Yuan Cheng Group Guaifenesin (API) Corporation Information
Table 64. Yuan Cheng Group Corporation Information
Table 65. Yuan Cheng Group Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 66. Yuan Cheng Group Main Product
Table 67. Yuan Cheng Group Recent Development
Table 68. Stellar Chemical Guaifenesin (API) Corporation Information
Table 69. Stellar Chemical Corporation Information
Table 70. Stellar Chemical Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 71. Stellar Chemical Main Product
Table 72. Stellar Chemical Recent Development
Table 73. Biesterfeld Guaifenesin (API) Corporation Information
Table 74. Biesterfeld Corporation Information
Table 75. Biesterfeld Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 76. Biesterfeld Main Product
Table 77. Biesterfeld Recent Development
Table 78. Seven Star Pharma Guaifenesin (API) Corporation Information
Table 79. Seven Star Pharma Corporation Information
Table 80. Seven Star Pharma Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 81. Seven Star Pharma Main Product
Table 82. Seven Star Pharma Recent Development
Table 83. Camlin Fine Science Guaifenesin (API) Corporation Information
Table 84. Camlin Fine Science Corporation Information
Table 85. Camlin Fine Science Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 86. Camlin Fine Science Main Product
Table 87. Camlin Fine Science Recent Development
Table 88. Gennex Lab Guaifenesin (API) Corporation Information
Table 89. Gennex Lab Corporation Information
Table 90. Gennex Lab Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 91. Gennex Lab Main Product
Table 92. Gennex Lab Recent Development
Table 93. Iwaki Seiyaku Guaifenesin (API) Corporation Information
Table 94. Iwaki Seiyaku Corporation Information
Table 95. Iwaki Seiyaku Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 96. Iwaki Seiyaku Main Product
Table 97. Iwaki Seiyaku Recent Development
Table 98. Pan Drugs Guaifenesin (API) Corporation Information
Table 99. Pan Drugs Corporation Information
Table 100. Pan Drugs Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 101. Pan Drugs Main Product
Table 102. Pan Drugs Recent Development
Table 103. Delta Synthetic Guaifenesin (API) Corporation Information
Table 104. Delta Synthetic Corporation Information
Table 105. Delta Synthetic Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 106. Delta Synthetic Main Product
Table 107. Delta Synthetic Recent Development
Table 108. Smart Pharm Guaifenesin (API) Corporation Information
Table 109. Smart Pharm Corporation Information
Table 110. Smart Pharm Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 111. Smart Pharm Main Product
Table 112. Smart Pharm Recent Development
Table 113. Sales Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Guaifenesin (API) Distributors List
Table 116. Guaifenesin (API) Customers List
Table 117. Market Key Trends
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Global Guaifenesin (API) Sales (MT) Forecast by Type (2021-2026)
Table 121. Global Guaifenesin (API) Sales Market Share Forecast by Type (2021-2026)
Table 122. Global Guaifenesin (API) Revenue (Million US$) Forecast by Type (2021-2026)
Table 123. Global Guaifenesin (API) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 124. Global Guaifenesin (API) Sales (MT) Forecast by Application (2021-2026)
Table 125. Global Guaifenesin (API) Revenue (Million US$) Forecast by Application (2021-2026)
Table 126. Global Guaifenesin (API) Sales (MT) Forecast by Region (2021-2026)
Table 127. Global Guaifenesin (API) Sales Market Share Forecast by Region (2021-2026)
Table 128. Global Guaifenesin (API) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Global Guaifenesin (API) Revenue Market Share Forecast by Region (2021-2026)
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Guaifenesin (API)
Figure 2. Global Guaifenesin (API) Sales Market Share by Type: 2020 VS 2026
Figure 3. 98%-99% Product Picture
Figure 4. >99% Product Picture
Figure 5. Global Guaifenesin (API) Consumption Market Share by Application: 2020 VS 2026
Figure 6. Pharmaceuticals
Figure 7. Others
Figure 8. Global Guaifenesin (API) Market Size 2015-2026 (US$ Million)
Figure 9. Global Guaifenesin (API) Sales Capacity (MT) (2015-2026)
Figure 10. Global Guaifenesin (API) Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Guaifenesin (API) Sales Share by Manufacturers in 2020
Figure 12. Global Guaifenesin (API) Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Guaifenesin (API) Revenue in 2019
Figure 14. Guaifenesin (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Guaifenesin (API) Sales Market Share by Region (2015-2020)
Figure 16. Global Guaifenesin (API) Sales Market Share by Region in 2019
Figure 17. Global Guaifenesin (API) Revenue Market Share by Region (2015-2020)
Figure 18. Global Guaifenesin (API) Revenue Market Share by Region in 2019
Figure 19. North America Guaifenesin (API) Sales Market Share by Country in 2019
Figure 20. North America Guaifenesin (API) Revenue Market Share by Country in 2019
Figure 21. U.S. Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 22. U.S. Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 24. Canada Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Guaifenesin (API) Sales Market Share by Country in 2019
Figure 26. Europe Guaifenesin (API) Revenue Market Share by Country in 2019
Figure 27. Germany Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 28. Germany Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 30. France Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 32. U.K. Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 34. Italy Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 36. Russia Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Guaifenesin (API) Sales Market Share by Region in 2019
Figure 38. Asia Pacific Guaifenesin (API) Revenue Market Share by Region in 2019
Figure 39. China Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 40. China Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 42. Japan Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 44. South Korea Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 46. India Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 48. Australia Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 50. Taiwan Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 52. Indonesia Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 54. Thailand Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 56. Malaysia Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 58. Philippines Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 60. Vietnam Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America Guaifenesin (API) Sales Market Share by Country in 2019
Figure 62. Latin America Guaifenesin (API) Revenue Market Share by Country in 2019
Figure 63. Mexico Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 64. Mexico Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 66. Brazil Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 68. Argentina Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa Guaifenesin (API) Sales Market Share by Country in 2019
Figure 70. Middle East and Africa Guaifenesin (API) Revenue Market Share by Country in 2019
Figure 71. Turkey Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 72. Turkey Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 74. Saudi Arabia Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. U.A.E Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 76. U.A.E Guaifenesin (API) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of Guaifenesin (API) by Type (2015-2020)
Figure 78. Sales Market Share of Guaifenesin (API) by Type in 2019
Figure 79. Revenue Share of Guaifenesin (API) by Type (2015-2020)
Figure 80. Revenue Market Share of Guaifenesin (API) by Type in 2019
Figure 81. Global Guaifenesin (API) Sales Growth by Type (2015-2020) (MT)
Figure 82. Global Guaifenesin (API) Sales Market Share by Application (2015-2020)
Figure 83. Global Guaifenesin (API) Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of Guaifenesin (API) by Application (2015-2020)
Figure 85. Global Revenue Share of Guaifenesin (API) by Application in 2020
Figure 86. Granules Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Synthokem Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Haizhou Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Yuan Cheng Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Stellar Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Biesterfeld Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Seven Star Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Camlin Fine Science Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Gennex Lab Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Iwaki Seiyaku Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Pan Drugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Delta Synthetic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Smart Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Price Trend of Key Raw Materials
Figure 100. Manufacturing Cost Structure of Guaifenesin (API)
Figure 101. Manufacturing Process Analysis of Guaifenesin (API)
Figure 102. Guaifenesin (API) Industrial Chain Analysis
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Porter's Five Forces Analysis
Figure 106. North America Guaifenesin (API) Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 107. North America Guaifenesin (API) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Guaifenesin (API) Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Guaifenesin (API) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Guaifenesin (API) Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Guaifenesin (API) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Guaifenesin (API) Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Guaifenesin (API) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Guaifenesin (API) Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Guaifenesin (API) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed
  • Global Guaifenesin (API) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 122
    According to our LPI (LP Information) latest study, the global Guaifenesin (API) market size was valued at US$ 73 million in 2023. With growing demand in downstream market, the Guaifenesin (API) is forecast to a readjusted size of US$ 96.8 million by 2030 with a CAGR of 4.0% during review period. The research report highlights the growth potential of the global Guaifenesin (API) market. Guaifenesin (API) are expected to show stable growth in the future market. However, product differenti......
  • Global Acetaminophen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 133
    According to our LPI (LP Information) latest study, the global Acetaminophen market size was valued at US$ 970.9 million in 2023. With growing demand in downstream market, the Acetaminophen is forecast to a readjusted size of US$ 1081.7 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Acetaminophen market. Acetaminophen are expected to show stable growth in the future market. However, product differentiation, redu......
  • Global Guaifenesin (API) Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122
    Report Overview: Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways. The Global Guaifenesin (API) Market Size was estimated at USD 98.30 million in 2022 and is projected to reach USD 128.49 million by 2029, exhibiting......
  • Global Guaifenesin Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: The Global Guaifenesin Market Size was estimated at USD 97.90 million in 2022 and is projected to reach USD 127.11 million by 2029, exhibiting a CAGR of 3.80% during the forecast period. This report provides a deep insight into the global Guaifenesin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and chall......
  • 2023-2031 Report on Global Acetaminophen Market by Player, Region, Type, Application and Sales Channel
    Published: 14-Nov-2023        Price: US 2500 Onwards        Pages: 100
    This report studies the Acetaminophen market, covering market size for segment by type (Powder Grade, Direct Compression Grade, etc.), by application (Tablet Drug, Granule Drug, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Mallinckrodt, Farmson, Granules India, SKPL, Atabay, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Acetamino......
  • Global Guaifenesin (API) Market Research Report 2023, Forecast to 2028
    Published: 10-Nov-2023        Price: US 2680 Onwards        Pages: 164
    Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advan......
  • Global Guaifenesin (API) Professional Survey Report 2023, Forecast to 2028
    Published: 10-Nov-2023        Price: US 3280 Onwards        Pages: 105
    Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advan......
  • Global Otc Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Nov-2023        Price: US 3380 Onwards        Pages: 124
    Market Overview of Global Otc Drugs market: According to our latest research, the global Otc Drugs market looks promising in the next 5 years. As of 2022, the global Otc Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Otc Drugs market, with a systematical descri......
  • Global Acetaminophen Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Sep-2023        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Acetaminophen market: According to our latest research, the global Acetaminophen market looks promising in the next 5 years. As of 2022, the global Acetaminophen market was estimated at USD 1057.38 million, and it's anticipated to reach USD 1309.23 million in 2028, with a CAGR of 3.62% during the forecast years. Acetaminophen, commonly known as Paracetamol is the most widely used analgesic and antipyretic that relieves pain and reduce fever. Discover......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs